Welcome to eBioscience   Tel: 888.999.1371 or 858.642.2058
Fax: 858.642.2046
Web: www.ebioscience.com
E-mail: info@ebioscience.com

Product Information


Contents: 14-3-3 (N19) Blocking Peptide
Catalog Number: 66-P768
Sizes: 50 ug
Formulation: Each vial contains 100 μg of peptide in 0.5 ml PBS with 0.1% NaN3 and 100 μg BSA.
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
 
 

 

Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications
66-P768 Blocking Peptides for anti-mouse/human/rat 14-3-3 polyclonal N/A N/A WB 

Custom Product Requests
Need a custom product? Download the Custom Product Request Form and submit completed form to customs@ebioscience.com.

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.

Description


This is a peptide mapping to the amino terminal domain of human 14-3-3. 14-3-3 family of proteins is composed of seven isotypes, beta, gamma, zeta, epsilon, tau, eta, and sigma, that play critical roles in cell signaling events that control cell cycle progression, transcriptional alterations, and apoptosis (1-4). 14-3-3 proteins were the first signaling molecules to be identified as specific phosphoserine/threonine binding proteins (1). 14-3-3 can serve as a direct regulator of its target by altering the function of the protein (3). 14-3-3 protein targets include the signalling intermediates Raf, MEKK, PI-3 kinase and IRS-1, cell cycle proteins CDK2, Wee1, and Cdc25, and apoptosis proteins BAD and ASK-1 (3,4).


Applications Reported


For research use only, not for diagnostic or therapeutic use. This blocking peptide has been reported for use in competition studies.


References



1. Yaffe MB. 2002. How do 14-3-3 proteins work?- - Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513(1):53-57.
2. Liu MY, Cai S, Espejo A, Bedford MT, Walker CL. 2002. 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation sites. Cancer Res. 62(22): 6475-6480.
3. Tzivion G, Shen YH, Zhu J. 2001. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20(44):6331-6338.
4. Fu H, Subramanian RR, Masters SC. 2000. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol. 40:617-647.


Related Products


Cat. 14-6768  Purified anti-mouse/human/rat 14-3-3 polyclonal (clone Polyclonal)



Copyright © 2000-2008 eBioscience, Inc.
For Research Use Only. Not for use in diagnostic procedures. Not for further distribution without written consent.